Skip to content
777 Sourcing.

Capability

TDP-43 inhibition

Suppliers
1
States & provinces
1
Countries
1

1 tdp-43 inhibition supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ALTERON THERAPEUTICS INC.

NAPLES, FL

Alteron Therapeutics develops first-in-class TDP-43 inhibitors, the ALTA drug series, to find cures for neurodegeneration and cystic fibrosis. The company targets TDP-43 toxicity, which contributes to ALS, Alzheimer's disease, and frontotemporal lobar degeneration. Its leading drug candidate is orally bioavailable, crosses the blood-brain barrier, and shows potential to reverse ALS symptoms.

drug developmentmolecular dockingNMR structures

Compiled from public sources

Related capabilities

Other processes offered by the shops that list TDP-43 inhibition.

Browse all capabilities